This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: British Columbia Cancer Agency Branch. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations in Cancer Research by Yuanmei Lou
Introduction
Yuanmei Lou is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of cancer research, particularly in understanding tumor metastatic potential. His work focuses on identifying biomarkers that can help assess the malignancy of cancers, especially those with hypoxic regions.
Latest Patents
Yuanmei Lou holds a patent for a method that determines tumor metastatic potential using specific biomarkers. The patent includes biomarkers such as carbonic anhydrase-9 (CAIX), vascular endothelial growth factor C (VEGF-C), and others. These biomarkers can indicate varying levels of metastatic potential, which is crucial for assessing cancers like breast cancer.
Career Highlights
Yuanmei Lou is associated with the British Columbia Cancer Agency Branch, where he continues to advance cancer research. His innovative approach to utilizing biomarkers has the potential to improve cancer diagnostics and treatment strategies.
Collaborations
Yuanmei has collaborated with notable colleagues, including Paul Christopher McDonald and Arusha Oloumi. These collaborations enhance the research efforts in the field of cancer metastasis.
Conclusion
Yuanmei Lou's contributions to cancer research through his innovative patent highlight the importance of biomarkers in understanding tumor behavior. His work is paving the way for advancements in cancer diagnostics and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile